Comparison of glycemic variations in Japanese patients with type 2 diabetes, between metformin high dose group and combination of metformin and sitagliptin or linagliptin group as assessed by continuous glucose monitoring (CGM)

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 26 Sep 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Linagliptin (Primary) ; Metformin (Primary) ; Sitagliptin (Primary)
Indications Type 2 diabetes mellitus
Focus Therapeutic Use

Most Recent Events

18 Sep 2018 Status changed from recruiting to completed.
26 Jun 2018 Results (n=11) assessing the effect of high dose metformin or combination of low dose metformin and linagliptin on glycemic variability in Japanese type 2 diabetes patients, presented at the 78th Annual Scientific Sessions of the American Diabetes Association.
22 Sep 2015 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight